Global /South Korea /Healthcare /Drug Manufacturers - General /389650

Next Biomedical Co.,Ltd.

389650

• KRX: 389650 • Delayed

59,400KRW -2.1%

38.75 USD

As of 5 June 2026, Next Biomedical Co.,Ltd. has a market cap of $318.45M USD, ranking #18256 globally and #590 in South Korea. It ranks #1660 in the Healthcare sector, and #600 in the Drug Manufacturers - General industry.

Global Rank

18256

Country Rank

590

Sector Rank

1660

Industry Rank

600

Key Stats

Market Cap

$318.45MUSD

488.13B KRW

Enterprise Value

$299.35MUSD

458.85B KRW

Revenue (TTM)

$10.75MUSD

16.48B KRW

EBITDA (TTM)

-$131.15KUSD

-201.04M KRW

Net Income (TTM)

-$202.95KUSD

-311.08M KRW

EBITDA Margin

-1.2%

Profit Margin

-1.9%

PS Ratio

29.6

PB Ratio

10.1

Company Profile

Country (HQ)

South Korea

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Donhaeng Lee open_in_new

Founded

2014

Website

nextbiomedical.co.kr open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
-2.1%	-0.2%	-23%	-20%	-4.3%	-32%	47%	76%	76%

News

Markets

Exchange	Ticker	Price	Quotes
Korea Exchange (KRX) MIC: XKRX PRIMARY	389650 주식회사 넥스트바이오메디컬 ISIN: KR7389650003 Shares Out.: Shares Outstanding: 8.277M¹ Shares Float: 6.028M² TV: TradingView: KRX: 389650 SA: Stock Analysis: KRX: 389650 YF: Yahoo Finance: 389650.KS GF: Google Finance: KRX: 389650 BA: Barron's: 389650 MS: Morningstar: XKRX: 389650	59,400 KRW	TV: TradingView: KRX: 389650 SA: Stock Analysis: KRX: 389650 YF: Yahoo Finance: 389650.KS GF: Google Finance: KRX: 389650 BA: Barron's: 389650 MS: Morningstar: XKRX: 389650

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Next Biomedical Co.,Ltd.

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea.

Similar Companies

Industry: Drug Manufacturers - General (South Korea)

Name	Market Cap (USD) diff.	PE	Country
Samsung Epis Holdings Co., Ltd. KRX: 0126Z0	$9.07B 13.91T KRW 3K%	-	South Korea
Sam Chun Dang Pharm. Co., Ltd. KRX: 000250	$6.72B 10.3T KRW 2K%	1958.1	South Korea
SK Biopharmaceuticals Co., Ltd. KRX: 326030	$5.2B 7.97T KRW 2K%	29.9	South Korea
ABL Bio Inc. KRX: 298380	$4.92B 7.55T KRW 1K%	-	South Korea
Yuhan Corp. KRX: 000100	$4.51B 6.92T KRW 1K%	35.9	South Korea
LigaChem Biosciences Inc. KRX: 141080	$4.41B 6.76T KRW 1K%	-	South Korea

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 239K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 172K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 113K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 102K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.25B 215.59B GBP 91K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 87K%	20.5	Switzerland

chevron_leftBack